Uptake and tolerance of chemotherapy in elderly patients with small cell lung cancer and impact on survival

Journal of Cancer Epidemiology

Volumn , Issue , 2012, Pages

  Fisher, Stacey ^a   Al Fayea, Turki M ^b   Winget, Marcy ^a   Gao, He ^a   Butts, Charles ^a,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c ALBERTA HEALTH SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ADULT; AGED; AGING; ARTICLE; CANADA; CANCER MORTALITY; CANCER REGISTRY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE REDUCTION; DRUG TOLERANCE; DRUG TOXICITY; DRUG UPTAKE; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICAL SPECIALIST; MULTIPLE CYCLE TREATMENT; ONCOLOGIST; OVERALL SURVIVAL; PRIORITY JOURNAL;

EID: 84871844413     PISSN: 16878558     EISSN: 16878566     Source Type: Journal    
DOI: 10.1155/2012/708936     Document Type: Article

References (29)

1. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
2. Simon G. R., Turrisi A., Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007 132 supplement 3 S324 S339 2-s2.0-34848884868 10.1378/chest.07-1385
3. Jackman D. M., Johnson B. E., Small-cell lung cancer. The Lancet 2005 366 9494 1385 1396 2-s2.0-26644438582 10.1016/S0140-6736(05)67569-1 (Pubitemid 41443406)
4. Kurup A., Hanna N. H., Treatment of small cell lung cancer. Critical Reviews in Oncology/Hematology 2004 52 2 117 126 2-s2.0-6944224365 10.1016/j.critrevonc.2004.08.005 (Pubitemid 39410539)
5. Canadian Cancer Society's Steering Committee on Cancer Statistics, Canadian Cancer Statistics 2012 2012 Toronto, ON, Canada Canadian Cancer Society
6. Pallis A. G., Shepherd F. A., Lacombe D., Gridelli C., Treatment of small-cell lung cancer in elderly patients. Cancer 2010 116 5 1192 1200 2-s2.0-77149128945 10.1002/cncr.24833
7. Ludbrook J. J. S., Truong P. T., MacNeil M. V., Lesperance M., Webber A., Joe H., Martins H., Lim J., Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population analysis. International Journal of Radiation Oncology Biology Physics 2003 55 5 1321 1330 2-s2.0-0037376515 10.1016/S0360-3016(02)04576-5 (Pubitemid 36338300)
8. Janssen-Heijnen M. L. G., Schipper R. M., Razenberg P. P. A., Crommelin M. A., Coebergh J. W. W., Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer 1998 21 2 105 113 2-s2.0-0032432786 10.1016/S0169-5002(98)00039-7 (Pubitemid 29028028)
9. Hutchins L. F., Unger J. M., Crowley J. J., Coltman C. A., Albain K. S., Underrepresentation of patients 65 years of age or older in cancer- treatment trials. New England Journal of Medicine 1999 341 27 2061 2067 2-s2.0-0033619959 10.1056/NEJM199912303412706 (Pubitemid 30035956)
10. Balducci L., Geriatric oncology: challenges for the new century. European Journal of Cancer 2000 36 14 1741 1754 2-s2.0-0033870822 10.1016/S0959-8049(00) 00169-6 (Pubitemid 30639493)
11. Yee K. W. L., Pater J. L., Pho L., Zee B., Siu L. L., Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier? Journal of Clinical Oncology 2003 21 8 1618 1623 2-s2.0-0038518557 10.1200/JCO.2003.12.044 (Pubitemid 46594117)
12. Johnson D. H., Treatment of the elderly patient with small-cell lung cancer. Chest 1992 103 1 2-s2.0-0027056434
13. Lichtman S. M., Skirvin J. A., Vemulapalli S., Pharmacology of antineoplastic agents in older cancer patients. Critical Reviews in Oncology/Hematology 2003 46 2 101 114 2-s2.0-0345204090 10.1016/S1040-8428(02) 00120-8 (Pubitemid 36444629)
14. Yancik R., Havlik R. J., Wesley M. N., Ries L., Long S., Rossi W. K., Edwards B. K., Cancer and comorbidity in older patients: a descriptive profile. Annals of Epidemiology 1996 6 5 399 412 2-s2.0-0030248903 10.1016/S1047-2797(96) 00063-4 (Pubitemid 26372528)
15. Rubenstein L. Z., Josephson K. R., Nichol-Seamons M., Robbins A. S., Comprehensive health screening of well elderly adults: an analysis of a community program. Journals of Gerontology 1986 41 3 342 352 2-s2.0-0022506711 (Pubitemid 16069326)
16. Shields M., Martel L., Healthy living among seniors. Health Report 2006 16 S7 S20 2-s2.0-33748096419
17. Lebitasy M. P., Hédelin G., Purohit A., Moreau L., Klinzig F., Quoix E., Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994. British Journal of Cancer 2001 85 6 808 815 2-s2.0-0035860148 10.1054/bjoc.2001.1955 (Pubitemid 33010545)
18. Weinmann M., Jeremic B., Bamberg M., Bokemeyer C., Treatment of lung cancer in elderly part II: small cell lung cancer. Lung Cancer 2003 40 1 1 16 2-s2.0-0037378433 10.1016/S0169-5002(02)00524-X (Pubitemid 36344062)
19. Monfardini S., Ferrucci L., Fratino L., Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer 1996 77 2 395 401 10.1002/(SICI)1097-0142(19960115)77:2<395::AID-CNCR24>3.0.CO;2-W (Pubitemid 26023359)
20. Statistics Canada, Population, urban and rural, by province and territory (Alberta table). Population, urban and rural, by province and territory, Population estimates and projection, Population and democracy, Summary Tables, 2006, last updated September 22, 2009, http://www.isesd.cv.ic.ac.uk/, 2012
21. Fritz, Percy C., Jack A., International Classification of Diseases For Oncology 2000 3rd Geneva, Switzerland World Health Organization
22. Tucker T. C., Howe H. L., Weir H. K., Certification for population-based cancer registries. Journal of Registry Management 1999 26 24 27
23. Shibata K., Kasahara K., Nakatsumi Y., Bando T., Fuigmura M., Matsuda T., Carboplatin plus etoposide in the treatment of small cell lung cancer. Lung Cancer 1997 18 supplement 1 54
24. Matsui K., Masuda N., Fukuoka M., Yana T., Hirashima T., Komiya T., Kobayashi M., Kawahara M., Atagi S., Ogawara M., Negoro S., Kudoh S., Furuse K., Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer. British Journal of Cancer 1998 77 11 1961 1965 2-s2.0-0031799126
25. Okamoto H., Watanabe K., Nishiwaki Y., Mori K., Kurita Y., Hayashi I., Masutani M., Nakata K., Tsuchiya S., Isobe H., Saijo N., Phase II study of area under the plasma-concentration-versus-time curve- based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer. Journal of Clinical Oncology 1999 17 11 3540 3545 2-s2.0-0032703877 (Pubitemid 29517925)
26. Larive S., Bombaron P., Riou R., Fournel P., Perol M., Lena H., Dussopt C., Philip-Joet F., Touraine F., Lecaer H., Souquet P. J., Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial. Lung Cancer 2002 35 1 1 7 2-s2.0-0036135190 10.1016/S0169-5002(01)00288-4 (Pubitemid 34028083)
27. Janssen-Heijnen M. L. G., Maas H. A. A. M., van de Schans S. A. M., Coebergh J. W. W., Groen H. J. M., Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it? Annals of Oncology 2011 22 4 821 826 2-s2.0-79953314268 10.1093/annonc/mdq448
28. Janssen-Heijnen M. L. G., Maas H. A. A. M., Siesling S., Koning C. C. E., Coebergh J. W. W., Groen H. J. M., Treatment and survival of patients with small-cell lung cancer: small steps forward, but not for patients >80. Annals of Oncology 2012 4 954 560
29. Gridelli C., De Vivo R., Monfardini S., Management of small-cell lung cancer in the elderly. Critical Reviews in Oncology/Hematology 2002 41 1 79 88 2-s2.0-0036142363 10.1016/S1040-8428(01)00163-9 (Pubitemid 34055731)